Myriad Genetics Gets A Boost From Direct-To-Consumer Ad Campaign
This article was originally published in The Pink Sheet Daily
Executive Summary
Myriad expects to spend more than $6 million this year on the ad campaigns, which include TV and print ads, direct mailings and a Web site directed at women with a family history of breast or ovarian cancers and at their health care providers.